Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs.

Containment 130

Containment Manufacturing Production Contract Manufacturing 130

Pharma Marketing Network

JUNE 17, 2021

Spreads also vary by industry sector with clinical research organizations and contract manufacturing having the lowest gaps at 8 percent with medical device companies at the highest at almost 22 percent with biopharma (pre-commercial) following at nearly 21 percent. Get the Full Report.

Life Science 52

Life Science Contract Manufacturing Business Development Clinical Research 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contract manufacturing market, which has fuelled contract commercial dose manufacturing and marketing. Discover the leading commercial dose companies in contract marketing.

Marketing 100

Marketing Contract Manufacturing Manufacturing Containment 100

The Pharma Data

JULY 29, 2021

Following the completion of the spin-off of the Upjohn Business(6) in the fourth quarter of 2020, Pfizer operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products worldwide.

Manufacturing 52

Manufacturing Sales Contract Manufacturing Vaccination 52

Drug Discovery World

SEPTEMBER 6, 2022

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . For cell and gene therapies, Covid-19 was a “double-edged sword”, according to Kristin Thompson, Chief Business Officer at eureKARE.

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

The Pharma Data

NOVEMBER 5, 2020

Business Highlights. Key Pipeline Progress Regeneron has more than 20 product candidates in clinical development, including five marketed products for which it is investigating additional indications. Corporate and Business Development Update. Research and development (R&D). $. government. Non-GAAP (1).

Sales 52

Sales Production Manufacturing Antibody 52

The Pharma Data

NOVEMBER 15, 2020

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. drug development initiative from 2012 to February 2019. Most recently, she was a senior executive at Celgene Corporation, where she led corporate strategy from 2012 to 2017.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021.

Vaccination 40

Vaccination Vaccine Production Sales 40